Schiffl Helmut
Department of Internal Medicine IV, University of Munich, Munich, Germany.
Kidney Dis (Basel). 2020 Jan;6(1):13-21. doi: 10.1159/000502209. Epub 2019 Oct 8.
The obesity epidemic is reflected by the rising number of obese patients requiring intensive care. Obesity is a recognized risk factor for the development of acute kidney injury (AKI) in critically ill patients. Both acute critical illness and AKI are associated with higher in-hospital mortality rates, and intensive care unit (ICU) patients suffering from AKI have an elevated risk of death. The relationships between obesity and mortality in critically ill paediatric and adult patients with or without AKI are less clear. Conflicting evidence exists regarding the potential impact of body mass index on the mortality of ICU patients with AKI. Some studies looking at the ICU outcomes of critically ill obese patients with AKI show reduced mortality and others show either no association or elevated mortality. Despite a high biologic plausibility of the proposed causal mechanisms, such as a greater haemodynamic stability and the protective cytokine, adipokine, and lipoprotein defence profiles associated with obesity, the inconsistency of the data suggests that the obesity paradox is a statistical fallacy and the result of chance, bias, and residual confounding variables in retrospective cohort analyses. Further prospective randomized trials are essential to elucidate the role of obesity and the mechanisms underlying a potential survival benefit of obesity in critically ill patients with AKI.
肥胖症流行体现在需要重症监护的肥胖患者数量不断增加。肥胖是危重症患者发生急性肾损伤(AKI)的公认危险因素。急性危重症和AKI均与较高的院内死亡率相关,患有AKI的重症监护病房(ICU)患者死亡风险升高。肥胖与患或未患AKI的危重症儿科和成年患者死亡率之间的关系尚不清楚。关于体重指数对AKI的ICU患者死亡率的潜在影响,存在相互矛盾的证据。一些针对患有AKI的危重症肥胖患者的ICU结局研究显示死亡率降低,而其他研究则显示无关联或死亡率升高。尽管所提出的因果机制具有较高的生物学合理性,例如与肥胖相关的更大的血流动力学稳定性以及保护性细胞因子、脂肪因子和脂蛋白防御特征,但数据的不一致表明肥胖悖论是一种统计谬误,是回顾性队列分析中机遇、偏差和残留混杂变量的结果。进一步的前瞻性随机试验对于阐明肥胖的作用以及肥胖在患有AKI的危重症患者中潜在生存获益的机制至关重要。